Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
US8497349B2 · kind B2 · utility
2Cited by
12References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2007 |
| Grant date | Jul 30, 2013 |
| Priority date | — |
| Expiry date | Aug 7, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating disorders involving deregulation of cell proliferation and/or angiogenesis comprising the administration of an effective amount of a multivalent synthetic compound comprising a support on which at least 3 pseudopeptide units are grafted, said compound being of formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.